Close Menu

NEW YORK (GenomeWeb) — Finnish diagnostics firm Mobidiag said today that it received CE-IVD marking for its Novodiag CarbaR+ test for carbapenemase-producing enterobacteriaceae (CPE), a bacteria resistant to carbapenem antibiotics.

The multiplex qPCR- and microarray-based test detects CPE and associated resistance markers, as well as a plasmid-mediated resistance for colistin, a last-resort antibiotic for many infections. It runs on the company's automated Novodiag system and produces results within 80 minutes.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Mar
21
Sponsored by
Loop Genomics

This webinar provides a comparison of next-generation sequencing (NGS) approaches for human transcriptome sequencing, including short-read Illumina sequencing and synthetic long-read sequencing technology.

Mar
26
Sponsored by
PerkinElmer

This webinar will address the current status and future directions for massively high-throughput genomics for plant and animal breeding and research.

Mar
27
Sponsored by
Swift Biosciences

Sequencing workflows require library quantification and normalization to ensure data quality and reduce cost. 

Mar
28
Sponsored by
Qiagen

The Human Gene Mutation Database (HGMD) is a manually curated, comprehensive collection of disease-causing, germline mutations. Since 1996, a team of experts has manually catalogued over a quarter of a million mutations for the database.